| Gene symbol | HLA-G | Synonyms | MHC-G | Type of gene | protein-coding |
| Chromosome | 6 | Map location | 6p22.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | major histocompatibility complex, class I, G | ||||
| GTO ID | GTC3297 |
| Trial ID | NCT05672459 |
| Disease | Solid Tumor |
| Altered gene | HLA-G |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | IVS-3001 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors |
| Year | 2023 |
| Country | United States |
| Company sponsor | M.D. Anderson Cancer Center |
| Other ID(s) | 2022-0261|NCI-2023-00020 |
| Cohort 1 | |||||||||||
|
|||||||||||